Health Catalyst

HCAT44

$7.90arrow_drop_down1.86%-$0.15

HCAT44

$7.90

arrow_drop_down1.86%-$0.15

Performance History

Key Stats
Open	$7.96
Prev. Close	$8.05
EPS	-1.49
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	7.78	7.96
52 Week Range	5.42	11.41

Ratios







EPS	-1.49

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Health Catalyst (HCAT)

Health Catalyst Inc (HCAT) is a leading provider of data and analytics technology solutions for the healthcare industry. The company offers a comprehensive suite of products and services that help healthcare organizations improve their clinical, financial, and operational outcomes. With a focus on data-driven insights, Health Catalyst empowers healthcare providers to make more informed decisions, optimize resource allocation, and deliver better patient care.

The stock price history of Health Catalyst Inc has shown steady growth since its initial public offering (IPO) in July 2019. Despite some fluctuations in the market, the stock has performed well overall, reflecting investors' confidence in the company's ability to drive innovation and create value in the healthcare sector. As of the latest available data, the stock is trading at $50.76 per share.

Websitecall_made

Sector: Healthcare
Industry: Health Information Services
CEO: Mr. Daniel D. Burton
Headquarters: South Jordan
Employees: 1200
Exchange: NASDAQ

Keep an eye on Health Catalyst

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of Health Catalyst (HCAT)?

Health Catalyst (HCAT) has a market capitalization of $486.79M. The average daily trading volume is 495.09K, indicating the stock's liquidity and investor engagement.

help

What is Health Catalyst 's (HCAT) price per share?

The current price per share for Health Catalyst (HCAT) is $7.9. The stock has seen a price change of -$0.15 recently, indicating a -1.86% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Health Catalyst (HCAT)?

For Health Catalyst (HCAT), the 52-week high is $11.41, which is 44.43% from the current price. The 52-week low is $5.42, the current price is 45.76% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Health Catalyst (HCAT) a growth stock?

Health Catalyst (HCAT) has shown an average price growth of 0.41% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Health Catalyst as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Health Catalyst (HCAT) stock price performance year to date (YTD)?

As of the latest data, Health Catalyst (HCAT) has a year-to-date price change of -13.38%. Over the past month, the stock has experienced a price change of 8.97%. Over the last three months, the change has been 29.51%. Over the past six months, the figure is 13.51%. Looking at a longer horizon, the five-year price change stands at -71.94%.

help

Is Health Catalyst (HCAT) a profitable company?

Health Catalyst (HCAT) has a net income of -$118.15M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 31.29% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -15.94% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $295.94M, with a revenue growth rate of 7.13%, providing insight into the company's sales performance and growth. The gross profit is $92.6M. Operating income is noted at -$85.76M. Furthermore, the EBITDA is -$41.7M.